Analysis of Key Market Segments Influencing the Plasma Therapy Market

The plasma therapy market is capturing increasing attention as advancements in regenerative medicine and clinical research open up new possibilities. With innovations in formulations and expanding applications across various medical fields, this sector is poised for significant growth in the coming years. Here, we explore the market size projections, key players, driving trends, and segmentation details shaping the future of plasma therapy.

Projected Expansion of the Plasma Therapy Market
The plasma therapy market is anticipated to experience rapid growth, reaching a valuation of $1.13 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 13.0%. Several factors contribute to this rise, including the advancement of sophisticated platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) formulations, increased research in regenerative medicine, and a broader application of plasma therapies for chronic and cardiac injuries. Additionally, sectors such as dermatology and dental care are adopting plasma therapy more widely, while the number of clinical trials and research institutions focusing on plasma treatments continues to grow.

Download a free sample of the plasma therapy market sample:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3278&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Plasma Therapy Market Growth Supported by Expanding Uses
The forecast period is marked by key trends such as the wider adoption of PRP and PRF therapies, especially in regenerative medicine and orthopedics. Applications are extending into dermatology, hair restoration, and plastic surgery, reflecting an increasing demand for injectable and membrane-based fibrin products. Moreover, integration between clinical research and therapeutic use is enhancing outcomes, driving further interest and investment in plasma therapy innovations.

Important Companies Leading the Plasma Therapy Industry
The plasma therapy market includes several prominent organizations, such as Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, and Proesis Biologics Inc.

View the full plasma therapy market report:
https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Significant Acquisition Enhancing Global Plasma Therapy Capabilities
In October 2025, Accord Plasma B.V., a Netherlands-based provider of plasma-derived therapies, acquired Prothya Biosolutions B.V., a US-based plasma collection and manufacturing firm specializing in plasma-derived products. Although the financial details were not disclosed, this acquisition aims to boost Accord Plasma B.V.'s global production efficiency, expand access to high-quality plasma products, and strengthen its position in the biopharmaceutical market.

Innovative Product Developments Influencing the Plasma Therapy Market
Market leaders are launching advanced products to meet evolving medical needs. For example, Olympus Corporation, based in Japan, released the ESG-410 electrosurgical generator in June 2023. This next-generation device is designed for treating non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH). The ESG-410 features enhanced capacitors that improve plasma stability during ignition and rapid startup times. Compared to its predecessor, the ESG-400, the ESG-410 offers superior performance and compatibility with various surgical tools, including resection loops, electrodes, and vaporization instruments, providing improved therapeutic options for NMIBC and BPH.

Detailed Segmentation of the Plasma Therapy Market
The plasma therapy market is divided into key segments based on type, application, and end-user:
1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair and Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals and Clinics, Laboratories, Research Institutes

Further subcategories include:
- Pure PRP subdivided into High Concentration PRP and Low Concentration PRP
- Leukocyte-rich PRP divided into PRP with White Blood Cells and PRP with Growth Factors
- Pure Platelet-rich Fibrin segmented into Injectable PRF and Membrane PRF
- Leukocyte-rich Fibrin split into L-PRF Clots and L-PRF Membranes

This detailed categorization helps in understanding the diverse applications and user groups within the plasma therapy market, supporting targeted growth strategies and innovation.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.